Dusan directs Two Sigma Ventures' investing at the intersection of life science/healthcare and data science, leveraging Two Sigma's quantitative and machine-learning heritage specifically into biotech, health IT, and data-services startups rather than being a generalist software investor. He brings an unusual combination of operator experience from helping launch business units inside a large AI-driven asset manager, deep healthcare domain expertise from his consulting background, and hands-on experience sourcing alternative data for investment algorithms—giving him an atypical perspective for a quant-hedge-fund-affiliated VC partner in life sciences.